0001358877-12-000002.txt : 20120130 0001358877-12-000002.hdr.sgml : 20120130 20120127190221 ACCESSION NUMBER: 0001358877-12-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120130 DATE AS OF CHANGE: 20120127 EFFECTIVENESS DATE: 20120130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIMERICK BIOPHARMA INC CENTRAL INDEX KEY: 0001358877 IRS NUMBER: 061735053 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-172591 FILM NUMBER: 12553160 BUSINESS ADDRESS: STREET 1: 181 28TH AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94121 BUSINESS PHONE: 650-742-0110 MAIL ADDRESS: STREET 1: 181 28TH AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94121 FORMER COMPANY: FORMER CONFORMED NAME: LIMERICK NEUROSCIENES INC DATE OF NAME CHANGE: 20060410 D 1 primary_doc.xml X0704 D LIVE 0001358877 LIMERICK BIOPHARMA INC 181 28TH AVENUE SAN FRANCISCO CA CALIFORNIA 94121 650-742-0110 CALIFORNIA Efflux Technology, Inc. LIMERICK NEUROSCIENES INC Corporation true Wendye Robbins c/o Limerick BioPharma, Inc. 181 28th Avenue San Francisco CA CALIFORNIA 94121 Executive Officer Director Corey Goodman c/o Limerick BioPharma, Inc. 181 28th Avenue San Francisco CA CALIFORNIA 94121 Director Pharmaceuticals Decline to Disclose 06 false 2012-01-05 false true true true true true Secured Convertible Promissory Notes (including (i) the shares of Preferred Stock issuable upon conversion of the Notes and (ii) the shares of Common Stock issuable upon conversion of the Preferred Stock). false 0 480000 480000 0 false 5 0 0 0 false LIMERICK BIOPHARMA INC /s/ Alan C. Mendelson Alan C. Mendelson Secretary 2012-01-27